The relationship between schizophrenia patients' attitudes towards physical health and the prevalence of metabolic syndrome

Purpose: Previous studies have established that metabolic syndrome (MetS) is associated with an increased risk of mortality. Several studies have demonstrated that the assessment of patients’ attitudes or behaviors regarding their physical health problems is an important parameter in initiating positive health behaviors and providing patients with metabolic control. To determine whether schizophrenia patients’ attitudes towards physical health affect the prevalence of MetS, we conducted a questionnaire survey of schizophrenia patients. Methods: We obtained 7,655 and 15,461 questionnaire responses from 520 and 247 facilities for outpatients and inpatients, respectively. The final analysis included data from a total of 6,576 subjects (2,213 outpatients and 4,363 inpatients). We assessed the effects of patients’ attitudes as risk factors for having MetS using multivariate logistic regression analysis. Results: The prevalence of MetS was higher in outpatients compared with inpatients (34.7% and 13.2%, respectively). Multivariate logistic regression analysis indicated that positive attitudes towards disease prevention and health care were related to a lower prevalence of MetS for outpatients and inpatients. In addition, greater knowledge of, and interest in, physical risk were associated with a lower prevalence of MetS only in outpatients. Conclusions: We detected substantial gaps in knowledge and negative health attitudes among respondents, suggesting that educational programs should be incorporated into current management protocols for patients with a high risk of MetS.

[1]  Mutaz M. Al-Debei,et al.  Self-Reported Adherence among Individuals at High Risk of Metabolic Syndrome: Effect of Knowledge and Attitude , 2016, Medical Principles and Practice.

[2]  Norio Sugawara,et al.  Difference in prevalence of metabolic syndrome between Japanese outpatients and inpatients with schizophrenia: A nationwide survey , 2016, Schizophrenia Research.

[3]  Norio Sugawara,et al.  High prevalence of underweight and undernutrition in Japanese inpatients with schizophrenia: a nationwide survey , 2015, BMJ Open.

[4]  D. Morisky,et al.  The influence of patients’ knowledge on adherence to their chronic medications: a cross-sectional study in Jordan , 2015, International Journal of Clinical Pharmacy.

[5]  Norio Sugawara,et al.  Psychiatrists' Attitudes toward Metabolic Adverse Events in Patients with Schizophrenia , 2014, PloS one.

[6]  S. Suryawati,et al.  Improving of Type 2 Diabetic Patients’ Knowledge, Attitude and Practice Towards Diabetes Self-care by Implementing Community-Based Interactive Approach-Diabetes Mellitus Strategy , 2012, BMC Research Notes.

[7]  J. Martínez-Ortega,et al.  Overweight and obesity in patients with bipolar disorder or schizophrenia compared with a non-psychiatric sample , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[8]  Norio Sugawara,et al.  Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia , 2011, Annals of general psychiatry.

[9]  H. Möller,et al.  Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level , 2011, World psychiatry : official journal of the World Psychiatric Association.

[10]  M. Yılmaz,et al.  The effect of the content of the knowledge on adherence to medication in hypertensive patients. , 2009, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.

[11]  Neil M. Johannsen,et al.  Metabolic Syndrome and Diabetes, Alone and in Combination, as Predictors of Cardiovascular Disease Mortality Among Men , 2009, Diabetes Care.

[12]  H. Rodbard,et al.  Self-reported prevalence and awareness of metabolic syndrome: findings from SHIELD , 2008, International journal of clinical practice.

[13]  J. Newcomer,et al.  Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data. , 2008, The Journal of clinical psychiatry.

[14]  M. Maj,et al.  Physical illness and schizophrenia: a review of the literature , 2007, Acta psychiatrica Scandinavica.

[15]  S. Kisely,et al.  Inequitable access for mentally ill patients to some medically necessary procedures , 2007, Canadian Medical Association Journal.

[16]  J. Peuskens,et al.  Body weight and self-esteem in patients with schizophrenia evaluated with B-WISE® , 2006, Schizophrenia Research.

[17]  J. Lieberman,et al.  Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline , 2006, Schizophrenia Research.

[18]  Craig W. Colton,et al.  Congruencies in Increased Mortality Rates, Years of Potential Life Lost, and Causes of Death Among Public Mental Health Clients in Eight States , 2006, Preventing chronic disease.

[19]  A. L. Dal-Fabbro,et al.  Adherence to long term therapies: evidence for action , 2005 .

[20]  T. Ratanasuwan,et al.  Health belief model about diabetes mellitus in Thailand: the culture consensus analysis. , 2005, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[21]  Daniel E Casey,et al.  Metabolic issues and cardiovascular disease in patients with psychiatric disorders. , 2005, The American journal of medicine.

[22]  J. de Leon,et al.  Obesity and associated complications in patients with severe mental illnesses: a cross-sectional survey. , 2005, The Journal of clinical psychiatry.

[23]  M. Tan The relationship of health beliefs and complication prevention behaviors of Chinese individuals with Type 2 Diabetes Mellitus. , 2004, Diabetes research and clinical practice.

[24]  L. Scott,et al.  Diabetes Update: Promoting Effective Disease Management , 2004, AAOHN journal : official journal of the American Association of Occupational Health Nurses.

[25]  S. De Geest,et al.  Adherence to Long-Term Therapies: Evidence for Action , 2003, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[26]  D. Allison,et al.  The impact of weight gain on quality of life among persons with schizophrenia. , 2003, Psychiatric services.

[27]  D. Allison,et al.  Antipsychotic-induced weight gain: a review of the literature. , 2001, The Journal of clinical psychiatry.

[28]  L. Groop,et al.  Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.

[29]  M. Daniel,et al.  Perceptions of disease severity and barriers to self-care predict glycemic control in Aboriginal persons with type 2 diabetes mellitus. , 2002, Chronic diseases in Canada.